Position in PTGX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$743,079
+$166,331 QoQ
Shares Held
6,062
+10.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#188
of 341 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $117,846,021 across 121 Biotechnology names. PTGX ranks #28 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,980 | $22,839,645 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,063 | $11,263,003 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30,242 | $9,103,749 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
40,460 | $7,577,348 | |
| 5 | INSM |
INSMED Inc
|
48,273 | $5,146,867 | |
| 6 | INCY |
Incyte Corp
|
29,027 | $3,290,500 | |
| 7 | RPRX |
Royalty Pharma plc
|
55,752 | $3,126,014 | |
| 8 | MRNA |
Moderna, Inc.
|
39,368 | $2,756,941 |
All Filings in PTGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $743,079 | 6,062 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $576,748 | 5,472 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $400,715 | 4,588 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $301,193 | 4,534 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $249,046 | 4,506 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $215,879 | 4,464 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||